Docetaxel in Treating Children With Recurrent Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of docetaxel in treating children with recurrent
solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing
so they stop growing or die.